The Emicizumab assay is now performed in special coagulation at QEHB. Samples are no longer referred to Birmingham Children's Hospital.
Emicizumab (or Hemlibra) is a monoclonal antibody that mimics the function of factor VIII by bridging activated factor IX and factor X to restore the function of missing activated factor VIII, which is needed for haemostasis.
ADAMTS13 Activity, HIT Screens and Collagen Binding (vW:CBA) Assays are now performed by automated chemiluminescent immunoassay on the Acustar analsyer.
Please see individual test information for updated reference ranges.
Due to supply issues there has been a change to the manufacturer of our malaria antigen kits effective from 26/08/2022 . The new test kit has been verified and is awaiting ISO accreditation at our next UKAS visit.
Queen Elizabeth pathology services are are based at Queen Elizabeth Hospital - University Hospitals Birmingham - Edgbaston. The laboratories are part of a wider laboratory grouping for University Hospitals Birmingham, which includes laboratories from Heartlands Hospital, Good Hope Hospital and Solihull Hospital (HGS Laboratories). All laboratories are ISO 15189 accreditated for their listed repertoire, unless otherwise noted. Site specific information can be accessed below.